Category: ROOT

3 physician burnout prevention strategies

Luis Garcia, MD, president of Sioux Falls, S.D.-based Sanford Health, shared three well-being priorities that can reduce physician burnout on a Becker’s webinar, sponsored by the American Medical Association.

1st treatment plan for onset of Type 1 diabetes to cost $194K

The nation’s first drug approved to delay the onset of stage 3 Type 1 diabetes is expected to cost $13,850 per vial, the drugmaker said Nov. 18. 

Maine hospital nurses to see 10%-11% wage increase over 3 years

Members of the Maine State Nurses Association have approved a new contract with Millinocket (Maine) Regional Hospital that includes raises.

The state of hospital executive burnout

Among healthcare C-suite executives, burnout appears to be on the rise, according to a survey from executive search firm WittKieffer.

Why Epic won’t invest in other companies

Epic has entered into big partnerships this year with Amazon Web Services and Google, and added capabilities to the MyChart app. The company also joined the Trusted Exchange Framework and Common Agreement to improve health data interoperability and lau…

Intermountain’s income hits $2.2B

Salt Lake City-based Intermountain Healthcare reported higher year-over-year net income for the nine months ending Sept. 30 after completing the acquisition of Broomfield, Colo.-based SCL Health on March 31.

SCA Health leader talks keys to success

Health provider SCA Health has 89 ASCs on Newsweek’s list of the best ASCs in the nation in 2022. Its vice president of marketing, communications and events, Blair Primis, shared some of the organization’s keys to success with Becker’s. 

Prime Healthcare hit with credit downgrade

Moody’s Investors Service has downgraded the ratings on Prime Healthcare’s probability of default rating to “B2-PD” from “B1-PD” as well as its ratings of the system’s senior secured notes to “B3” from “B2.”

Teva names CEO

Teva Pharmaceuticals named Richard Francis as its next president and CEO, effective Jan. 1. 

29 amoxicillin and clavulanate products on back order

Among three drugmakers, 29 amoxicillin and clavulanate oral presentations are on allocation or back order, according to the American Society of Health-System Pharmacists.